Oramed Pharmaceuticals (ORMP) Payables (2011 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Payables came in at $8.7 million in Q1 2026, up 64.17% YoY from $5.3 million in Q1 2025, and up 536.42% on a QoQ basis from $1.4 million in Q4 2025.
Oramed Pharmaceuticals (ORMP) Payables (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 16 years of Payables data on file, last reported at $8.7 million in Q1 2026.
- Quarterly Payables rose 64.17% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (up 64.17% YoY) and the FY2025 annual result came in at $1.4 million, down 74.95% from the prior year.
- Payables grew to $8.7 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Payables ranged from a high of $51.6 million in Q4 2023 to a low of $749000.0 in Q2 2025.
- A 5-year average of $9.9 million and a median of $4.3 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables jumped 1139.82% — and 2024, when it tumbled 89.39%.
- Tracing ORMP's Payables over 5 years: stood at $4.2 million in 2022, then jumped by 1139.82% to $51.6 million in 2023, then tumbled by 89.39% to $5.5 million in 2024, then sank by 74.95% to $1.4 million in 2025, then surged by 536.42% to $8.7 million in 2026.
- The last three Payables figures came in at $8.7 million (Q1 2026), $1.4 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | 8.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.77 Mn |
| Mar 31, 2026 | 8.72 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | 749,000.00 |
| Mar 31, 2025 | 5.31 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | 33.30 Mn |
| Dec 31, 2023 | 51.56 Mn |
| Sep 30, 2023 | 27.56 Mn |
| Jun 30, 2023 | 831,000.00 |
| Mar 31, 2023 | 4.06 Mn |
| Dec 31, 2022 | 4.16 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 3.38 Mn |
| Nov 30, 2021 | 4.83 Mn |
| Aug 31, 2021 | 3.85 Mn |